The University of Chicago Header Logo

Connection

Thomas Gajewski to Blood Proteins

This is a "connection" page, showing publications Thomas Gajewski has written about Blood Proteins.
Connection Strength

0.249
  1. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 2004 Feb 01; 64(3):1140-5.
    View in: PubMed
    Score: 0.201
  2. B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med. 2003 Jun 16; 197(12):1721-30.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.